Pi-103 – the pik inhibitor
Free Online Articles Directory
Why Submit Articles?
Top Authors
Top Articles
FAQ
ABAnswers
0 && $.browser.msie ) {
var ie_version = parseInt($.browser.version);
if(ie_version Login
Register
Hello
My Home
Sign Out
Email
Password
Remember me?
Lost Password?
Home Page > Health > Medicine > Pi-103 – the pik inhibitor
Pi-103 – the pik inhibitor
Posted: Nov 22, 2011 |Comments: 0
|
]]>
BIOLOGICAL ACTIVITY OF PI-103:
Targeting the PI3K-AKT-mTOR pathway for treatment of various cancers is an effective strategy to reduce tumor cell proliferation, survival and migration. The over-expression of these molecules and the associated pathway has been linked to more than one type of cancers and hence the development of inhibitors targeting this pathway is seen as an efficacious strategy as they can be employed at a wider spectrum. PI-103 PI3K inhibitor is one such molecule that targets the aberrations in this pathway to inhibit PI3K, an action that leads to generate apoptotic response in cancer cells. It has been tested in various cell culture models made up of tumor cells and its efficacy has prompted the researchers and medical practitioners to use it at clinical level.
PHYSICAL PROPERTIES OF PI-103:
PI-103 structure shows that it is a pyridinylfuranopyrimidine molecule. This ATP-competitive inhibitor inhibits various PI3K family members and PI-103 IC50 for effective DNA-PK, p110α, mTORC1, PI3-KC2β, p110δ, mTORC2, p110β, and p110γ inhibition is 2 nM, 8 nM, 20 nM, 26 nM, 48 nM, 83 nM, 88 nM and 150 nM, respectively. Against other kinases though, it shows no specificity. PI-103 price is on the higher side only and one can buy PI-103′s 10 mg vial for around $150 from any PI-103 supplier. PI-103 solubility can be achieved in DMSO to give a 100 mM solution. PI-103 stability can be gained by storing it at +4°C after desiccation.
PHARMACOLOGICAL ASSESSMENT OF PI-103:
In difficult to treat glioma cells, PI-103 was shown to induce proliferative arrests by inhibiting both PI3Ka and mTOR. In tumor xenografts derived from malignant glioma cells, there was no toxicity reported upon PI-103 treatment [1]. PI-103 is metabolized extensively, but is distributed rapidly to tumor cells resulting in tumor growth delay in human tumor xenografts carrying PI3K pathway aberrations. PI-103 shows decreased angiogenesis in glioma cells and ovarian and breast cancer xenografts [2]. In leukemic cell lines derived from humans and in primary blast cells from acute myeloid leukemia (R406) patients, PI-103 was shown to inhibit growth factor-induced and/or constitutive mTORC1 and PI3K/Akt activation and it induced cell cycle arrest and mitochondrial apoptosis in these models [3].
]]>
PI-103 showed synergistic apoptotic effects when given with Etoposide to blast immature leukemic cells, sparing normal CD34 +ve cells [3]. In Gefitinib treatment-resistant non-small cell lung cancer (NSCLC) cells, PI-103 treatment induced apoptosis by inhibiting p70S6K and Akt phosphorylation. PI-103 downregulated cyclin D1 and E1 and activated p21, p53 and p27 to lead to a G0-G1 arrest. [4]. Its combination with Doxorubicin reduced colony formation and increased apoptosis drastically in comparison to chemotherapy alone and the underlying mechanism was shown as its inhibition of PI3K, DNA-PK and mTOR and concurrent doxorubicin-induced DNA damage to contribute to apoptosis in glioma cell lines and stem cells [5]. The DNA damage coupled with prolonged Rad 51 and γH2AX foci after PI-103 treatment contributes to G2-M delay [6]. It shows synergistic effects with Nutlin-3 also by inducing conformational changes in Bax and caspase-3 activation to dephosphorylate 4E-BP1 leading to decreased Mdm2, Noxa, p21, survivin and Bcl-2 expression [7]. In in vitro and in vivo glioma mouse models, a reduced proliferation and invasion coupled with G0–G1 arrest is seen upon PI-103′s co-treatment with secretable tumor necrosis factor apoptosis-inducing ligand (Perifosine) [8]. It kills non-APL leukemia cells in combination with Arsenic disulfide sparing normal hematopoietic stem cells [9]. Similarly it showed potent synergistic effects with TCN in Trp53 and Nf1 mutation carrying astrocytoma cells [10]. The success of these preclinical trials calls for PI-103 clinical trial.
REFERENCES:
1. Fan QW, e.a., A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell, 2006.
2. Raynaud FI, e.a., Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res., 2007.
3. Park S, e.a., PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia, 2008.
4. Zou ZQ, e.a., A novel dual PI3Kα/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells. International Journal of Molecular Medicine, 2009.
5. Westhoff MA, e.a., The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repairChemosensitization of glioblastoma by PI-103. Oncogene, 2009.
6. Prevo R, e.a., Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity. Cancer Res., 2008.
7. Kojima K, e.a., The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AMLPI-103 effects in p53 wild-type AML. Leukemia, 2008.
8. Onder TB, e.a., A Dual PI3K/mTOR Inhibitor, PI-103, Cooperates with Stem Cell-Delivered TRAIL in Experimental Glioma Models. Cancer Res., 2011.
9. Hong Z, e.a., Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation Carcinogenesis, 2011.
10. Gürsel DB, e.a., Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies. Neuro Oncol, 2011.
Retrieved from “http://www.articlesbase.com/medicine-articles/pi-103-the-pik-inhibitor-5419344.html”
Neuro -
About the Author:
We has established long-term and stable relationships with more than 10,000 customers from pharmaceutical and biotech companies, universities and research institutions. We have high quality inhibitors like Vismodegib, Olaparib, Navitoclax & more. We have headquarters in both United States and Europe, and also has 38 distributors worldwide. We provide overnight delivery in North America and Europe.
]]>
Questions and Answers
Ask our experts your Medicine related questions here…
200 Characters left
Ask
Rate this Article
vote(s)
0 vote(s)
0) {
ch_selected = Math.floor(Math.random()*ch_queries.length);
if(ch_selected == ch_queries.length) ch_selected–;
ch_query = ch_queries[ch_selected];
}
}catch(e){
ch_query = document.title;
}
]]>
Source: http://www.articlesbase.com/medicine-articles/pi-103-the-pik-inhibitor-5419344.html
Article Tags:
vismodegib, olaparib, navitoclax
Latest Medicine Articles
More from Neuro
Johnson & Johnson Shells Out $223 Million in Litigation, Additional DePuy ASR Recall Expenses
Johnson & Johnson’s third quarterly earnings report showed that the pharmaceutical had already incurred $223 million in litigation expenses and additional DePuy Articular Surface Replacement (ASR) hip recall cost from January to September this year.
By:
Katherine Russell
Health>
Medicinel
Nov 22, 2011
Nearly 20 Lawsuits Filed Daily Against DePuy ASR Hip Replacement
Court documents showed that nearly 20 lawsuits are filed everyday against DePuy Orthopaedics Inc. and its mother company Johnson & Johnson over its Articular Surface Replacement (ASR) hip systems.
By:
Katherine Russell
Health>
Medicinel
Nov 22, 2011
How To Revive Yourself With Gerovital H3
Gerovital H3 first came into prominence in the 1950s as an anti ageing treatment which was found to be not only one of the effective anti ageing cure available but also one of the safest method to revive your health and overall wellbeing for a new rejuvenated self.
By:
mac leol
Health>
Medicinel
Nov 22, 2011
How to Stay Young Using Hormone Replacement Therapy With Esnatri
Esnatri Replaces Your Vital Hormones Naturally
Since the development of hormone replacement therapy (HRT) in the 1920s, estrogens have been derived from horse urine because a more natural solution was too expensive to synthesize. Now a new estrogen cream offers a more natural solution. Esnatri is our triple estrogen cream, which women can use every day, confident they have chosen the best homeopathic estrogen cream available.
By:
DhirajSainil
Health>
Medicinel
Nov 22, 2011
The Function of PI3k-gamma on obesity
PI3k-gamma is now related to treatment of Obesity,not just limited to cancer research. Acually, researchers now found that PI3K signaling pathway is not onky targeted for cancer research, but for other abnormal cells as well. We have already characterized obesity as chronic low-grade inflammation. So targeting PI3K-gamma is to regulate the abnormal signaling pathway and turn the abnormal cell signal to normal situation.
By:
Neurol
Health>
Medicinel
Nov 22, 2011
The comparison of PI3K and p53
PI3K plays a role in p53 related signaling pathways and even take part in feedback loop of p53 controlled cell survival. All of those discoveries just beginning and more results and relationship are found by researchers. I would introduce later.
By:
Neurol
Health>
Medicinel
Nov 22, 2011
The function of PI3K on p53 (down-regulation)
HER2 and PI3K signaling pathway can lead to down-regulation of wild type p53 in breast cancer cells. Now I just gave some details about those research.
Researchers found that PI3K was over-activated in breast cancer cells because of over-expression of HER2.
By:
Neurol
Health>
Medicinel
Nov 22, 2011
SB939 inspects the spreading of tumors
A robustlinkmay beobservedbetween thevariationsinside thepatternsassociated with histone alterationsand differentkinds ofcancers. An idealstabilitybetween the histone acetylases along with histone deacetylases managesthe degreeregarding acetylation of histone meats.
By:
Neurol
Health>
Medicinel
Nov 21, 2011
Discuss this Article
Author Navigation
My Home
Publish Article
View/Edit Articles
View/Edit Q&A
Edit your Account
Manage Authors
Statistics Page
Personal RSS Builder
My Home
Edit your Account
Update Profile
View/Edit Q&A
Publish Article
Author Box
Neuro has 102 articles online
Articles Categories
All Categories
Advertising
Arts & Entertainment
Automotive
Beauty
Business
Careers
Computers
Education
Finance
Food and Beverage
Health
Hobbies
Home and Family
Home Improvement
Internet
Law
Marketing
News and Society
Relationships
Self Improvement
Shopping
Spirituality
Sports and Fitness
Technology
Travel
Writing
Acne
Allergies
Alternative Medicine
Anti Aging
Cancer
Dental Care
Disabilities
Diseases and Conditions
Hair Loss
Hearing
Medical Tourism
Medicine
Men’s Health
Mental Health
Nutrition
Plastic Surgeries
Quit Smoking
Sleep
Supplements & Vitamins
Vision
Wellness
Women’s Health
]]>
Need Help?
Contact Us
FAQ
Submit Articles
Editorial Guidelines
Blog
Site Links
Recent Articles
Top Authors
Top Articles
Find Articles
Site Map
Mobile Version
Webmasters
RSS Builder
RSS
Link to Us
Business Info
Advertising
Use of this web site constitutes acceptance of the Terms Of Use and Privacy Policy | User published content is licensed under a Creative Commons License.
Copyright © 2005-2011 Free Articles by ArticlesBase.com, All rights reserved.
We has established long-term and stable relationships with more than 10,000 customers from pharmaceutical and biotech companies, universities and research institutions. We have high quality inhibitors like Vismodegib, Olaparib, Navitoclax & more. We have headquarters in both United States and Europe, and also has 38 distributors worldwide. We provide overnight delivery in North America and Europe.
Article Source
Share this:
Read also:
- Why Medical Centers are Better Choices?
- Singapore Beach Holidays and Hotels in Singapore
- Financial Cost of Addiction vs. the Cost of an Addiction
- Traditional Chinese massage(Tui Na)
- PI3K and Non–Small-Cell Lung Cancer
- Health & Medical History of Dead Osama bin Laden